|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
increases transport |
ISO |
ABCB1 protein results in increased transport of N-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine |
CTD |
PMID:21436125 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of ABCB1 |
CTD |
PMID:11573427 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions decreases phosphorylation |
ISO |
BCL2 protein inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; N-acetylsphingosine inhibits the reaction [CAV1 protein results in increased phosphorylation of AKT1 protein]; N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein N-acetylsphingosine results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:12640124 PMID:16215670 PMID:21821001 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions decreases phosphorylation |
ISO |
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of BAD protein] |
CTD |
PMID:24420784 |
|
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bax |
BCL2-associated X protein |
increases expression multiple interactions |
ISO |
N-acetylsphingosine results in increased expression of BAX mRNA N-acetylsphingosine promotes the reaction [Acetaminophen results in increased expression of BAX protein] |
CTD |
PMID:24420784 PMID:33959992 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions decreases expression |
ISO |
BCL2 protein inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased degradation of PLCG1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 protein]; sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 mRNA]; sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 protein] N-acetylsphingosine results in decreased expression of BCL2 mRNA; N-acetylsphingosine results in decreased expression of BCL2 protein |
CTD |
PMID:9295281 PMID:16215670 PMID:24420784 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
multiple interactions increases degradation |
ISO |
LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of BCL2L1 protein] |
CTD |
PMID:21821001 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
[C2-ceramide cotreated with paclitaxel] decreases expression of BIRC2 mRNA in non-small cell lung cancer cells |
RGD |
PMID:20624405 |
RGD:152999014 |
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
[C2-ceramide cotreated with paclitaxel] decreases expression of BIRC3 mRNA in non-small cell lung cancer cells |
RGD |
PMID:20624405 |
RGD:152999014 |
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO EXP |
BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased cleavage of and results in increased activity of CASP3 protein]; N-acetylsphingosine promotes the reaction [Acetaminophen results in increased expression of CASP3 protein]; N-acetylsphingosine results in increased cleavage of and results in increased activity of CASP3 protein N-acetylsphingosine results in increased activity of CASP3 protein |
CTD |
PMID:10919278 PMID:16215670 PMID:21259059 PMID:28052715 PMID:33959992 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Cav1 |
caveolin 1, caveolae protein |
multiple interactions |
ISO |
N-acetylsphingosine inhibits the reaction [CAV1 protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:12640124 |
|
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions decreases localization |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of CEBPB protein]; N-acetylsphingosine inhibits the reaction [oltipraz results in increased localization of CEBPB protein] |
CTD |
PMID:15319326 |
|
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
|
|
G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of CFTR protein |
CTD |
PMID:15474513 |
|
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
|
|
G |
Cldn4 |
claudin 4 |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of CLDN4 mRNA; N-acetylsphingosine results in decreased expression of CLDN4 protein |
CTD |
PMID:28052715 |
|
NCBI chr 5:134,973,977...134,975,788
Ensembl chr 5:134,973,973...134,975,788
|
|
G |
Clk1 |
CDC-like kinase 1 |
increases expression |
EXP |
N-acetylsphingosine results in increased expression of CLK1 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr 1:58,451,147...58,463,247
Ensembl chr 1:58,449,348...58,463,225
|
|
G |
Ctsd |
cathepsin D |
increases secretion |
ISO |
N-acetylsphingosine results in increased secretion of CTSD protein |
CTD |
PMID:15040013 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Dapk1 |
death associated protein kinase 1 |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of DAPK1 protein |
CTD |
PMID:17087515 |
|
NCBI chr13:60,749,506...60,911,005
Ensembl chr13:60,749,761...60,911,005
|
|
G |
Dffb |
DNA fragmentation factor, beta subunit |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of DFFB protein |
CTD |
PMID:15040013 |
|
NCBI chr 4:154,048,904...154,059,578
Ensembl chr 4:154,048,906...154,059,583
|
|
G |
Dnm1l |
dynamin 1-like |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of DNM1L protein |
CTD |
PMID:18006463 |
|
NCBI chr16:16,130,092...16,176,863
Ensembl chr16:16,130,094...16,176,823
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
N-acetylsphingosine inhibits the reaction [EGF protein results in increased abundance of Diglycerides] |
CTD |
PMID:11082532 |
|
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
|
|
G |
F3 |
coagulation factor III |
increases expression multiple interactions |
ISO |
N-acetylsphingosine results in increased expression of F3 protein N-acetylsphingosine promotes the reaction [IL1B protein results in increased expression of F3 protein] |
CTD |
PMID:27556861 |
|
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
|
|
G |
Fis1 |
fission, mitochondrial 1 |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of FIS1 protein |
CTD |
PMID:18006463 |
|
NCBI chr 5:136,982,129...136,995,088
Ensembl chr 5:136,982,129...136,995,088
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble |
multiple interactions |
ISO |
N-acetylsphingosine promotes the reaction [Acetaminophen results in increased activity of GOT1 protein] |
CTD |
PMID:33959992 |
|
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
ISO |
N-acetylsphingosine promotes the reaction [Acetaminophen results in increased activity of GPT protein] |
CTD |
PMID:33959992 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
multiple interactions |
ISO |
N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased activity of GPX3 protein] |
CTD |
PMID:33959992 |
|
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
|
|
G |
Gsk3a |
glycogen synthase kinase 3 alpha |
decreases phosphorylation |
ISO |
N-acetylsphingosine results in decreased phosphorylation of GSK3A protein |
CTD |
PMID:21821001 |
|
NCBI chr 7:24,927,683...24,937,276
Ensembl chr 7:24,927,683...24,937,276
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases phosphorylation decreases expression multiple interactions |
ISO |
N-acetylsphingosine results in decreased phosphorylation of GSK3B protein N-acetylsphingosine results in decreased expression of GSK3B protein modified form GSK3B mutant form inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein] |
CTD |
PMID:21821001 PMID:24420784 |
|
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
|
|
G |
Gsta1 |
glutathione S-transferase, alpha 1 (Ya) |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of GSTA5 protein |
CTD |
PMID:15155840 |
|
NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966
|
|
G |
Gsta2 |
glutathione S-transferase, alpha 2 (Yc2) |
multiple interactions decreases expression |
ISO |
N-acetylsphingosine inhibits the reaction [2-tert-butylhydroquinone results in increased expression of GSTA2 protein]; N-acetylsphingosine inhibits the reaction [oltipraz results in increased expression of GSTA2 protein] N-acetylsphingosine results in decreased expression of GSTA2 protein |
CTD |
PMID:15155840 PMID:15319326 |
|
NCBI chr 9:78,238,300...78,254,474
Ensembl chr 9:78,238,300...78,263,070
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of HMOX1 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hnf1a |
HNF1 homeobox A |
multiple interactions decreases ubiquitination |
ISO |
N-acetylsphingosine results in decreased expression of and results in decreased activity of HNF1A protein N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased expression of HNF1A mRNA]; N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased expression of HNF1A protein] N-acetylsphingosine results in decreased ubiquitination of HNF1A protein |
CTD |
PMID:15155840 PMID:31385618 PMID:33959992 |
|
NCBI chr 5:115,087,039...115,109,121
Ensembl chr 5:115,087,039...115,109,153
|
|
G |
Hrk |
harakiri, BCL2 interacting protein (contains only BH3 domain) |
increases expression multiple interactions |
ISO |
N-acetylsphingosine results in increased expression of HRK mRNA N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [N-acetylsphingosine results in increased expression of HRK mRNA]; sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in increased expression of HRK mRNA] |
CTD |
PMID:24420784 |
|
NCBI chr 5:118,307,829...118,327,543
Ensembl chr 5:118,302,713...118,327,543
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of ID2 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139
|
|
G |
Il16 |
interleukin 16 |
increases expression |
EXP |
N-acetylsphingosine results in increased expression of IL16 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
N-acetylsphingosine promotes the reaction [IL1B protein results in increased expression of F3 protein] |
CTD |
PMID:27556861 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions |
ISO |
N-acetylsphingosine promotes the reaction [Acetaminophen results in increased phosphorylation of JUN protein] |
CTD |
PMID:33959992 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Kdr |
kinase insert domain protein receptor |
multiple interactions |
EXP ISO |
N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of KDR protein sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of KDR mRNA] |
CTD |
PMID:15313899 PMID:15741222 |
|
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
|
|
G |
Klf6 |
Kruppel-like transcription factor 6 |
increases expression |
EXP |
N-acetylsphingosine results in increased expression of KLF6 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr13:5,911,488...5,920,392
Ensembl chr13:5,911,481...5,920,393
|
|
G |
Lgals3 |
lectin, galactose binding, soluble 3 |
multiple interactions increases expression decreases response to substance |
ISO |
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein]; GSK3B mutant form inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein]; LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of BCL2L1 protein]; LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of MCL1 protein] LGALS3 results in decreased susceptibility to N-acetylsphingosine |
CTD |
PMID:21821001 |
|
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions |
ISO |
N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein; TXNIP affects the reaction [N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein] |
CTD |
PMID:18270325 |
|
NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of MAPK1 protein |
CTD |
PMID:10700234 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of MAPK3 protein |
CTD |
PMID:10700234 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
N-acetylsphingosine promotes the reaction [Acetaminophen results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:33959992 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO EXP |
N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein; TXNIP affects the reaction [N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein] |
CTD |
PMID:18270325 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mcl1 |
myeloid cell leukemia sequence 1 |
multiple interactions increases degradation |
ISO |
LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of MCL1 protein] |
CTD |
PMID:21821001 |
|
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
|
|
G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of MDM2 mRNA; N-acetylsphingosine results in decreased expression of MDM2 protein |
CTD |
PMID:18206046 |
|
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
|
|
G |
Mfn2 |
mitofusin 2 |
decreases response to substance |
ISO |
MFN2 protein results in decreased susceptibility to N-acetylsphingosine |
CTD |
PMID:18006463 |
|
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
|
|
G |
Mir15b |
microRNA 15b |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of MIR15B mRNA |
CTD |
PMID:20145152 |
|
NCBI chr 3:68,917,105...68,917,168
Ensembl chr 3:68,917,105...68,917,168
|
|
G |
Mir20a |
microRNA 20a |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of MIR20A mRNA |
CTD |
PMID:20145152 |
|
NCBI chr14:115,281,589...115,281,695
Ensembl chr14:115,281,589...115,281,695
|
|
G |
Mir25 |
microRNA 25 |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of MIR25 mRNA |
CTD |
PMID:20145152 |
|
NCBI chr 5:138,163,583...138,163,666
Ensembl chr 5:138,163,583...138,163,666
|
|
G |
Mir93 |
microRNA 93 |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of MIR93 mRNA |
CTD |
PMID:20145152 |
|
NCBI chr 5:138,163,785...138,163,872
Ensembl chr 5:138,163,785...138,163,872
|
|
G |
Mirlet7b |
microRNA let7b |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of MIRLET7B mRNA |
CTD |
PMID:20145152 |
|
NCBI chr15:85,591,520...85,591,604
Ensembl chr15:85,591,520...85,591,604
|
|
G |
Mirlet7d |
microRNA let7d |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of MIRLET7D mRNA |
CTD |
PMID:20145152 |
|
NCBI chr13:48,689,488...48,689,590
Ensembl chr13:48,689,488...48,689,590
|
|
G |
Mirlet7e |
microRNA let7e |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of MIRLET7E mRNA |
CTD |
PMID:20145152 |
|
NCBI chr17:18,050,614...18,050,706
Ensembl chr17:18,050,614...18,050,706
|
|
G |
Mirlet7i |
microRNA let7i |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of MIRLET7I mRNA |
CTD |
PMID:20145152 |
|
NCBI chr10:122,821,545...122,821,629
Ensembl chr10:122,821,545...122,821,629
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
multiple interactions decreases localization |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of NFE2L2 protein]; N-acetylsphingosine inhibits the reaction [2-tert-butylhydroquinone results in increased localization of NFE2L2 protein] |
CTD |
PMID:15319326 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
ISO |
N-acetylsphingosine affects the reaction [Glutathione affects the activity of NGF protein] |
CTD |
PMID:12381813 |
|
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
|
|
G |
Nrp1 |
neuropilin 1 |
multiple interactions |
ISO |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP1 mRNA] |
CTD |
PMID:15741222 |
|
NCBI chr 8:129,085,553...129,231,957
Ensembl chr 8:129,085,085...129,229,844
|
|
G |
Nrp2 |
neuropilin 2 |
multiple interactions |
ISO |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA] |
CTD |
PMID:15741222 |
|
NCBI chr 1:62,742,476...62,857,851
Ensembl chr 1:62,742,444...62,857,854
|
|
G |
Ocln |
occludin |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of OCLN mRNA; N-acetylsphingosine results in decreased expression of OCLN protein |
CTD |
PMID:28052715 |
|
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
|
|
G |
Odc1 |
ornithine decarboxylase, structural 1 |
decreases activity |
ISO |
N-acetylsphingosine results in decreased activity of ODC1 protein |
CTD |
PMID:17521618 |
|
NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of PARP1 protein |
CTD |
PMID:24420784 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pink1 |
PTEN induced putative kinase 1 |
decreases response to substance |
EXP ISO |
PINK1 protein results in decreased susceptibility to N-acetylsphingosine |
CTD |
PMID:24792327 |
|
NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618
|
|
G |
Plat |
plasminogen activator, tissue |
multiple interactions |
ISO |
[N-acetylsphingosine results in increased abundance of Ceramides] which results in increased secretion of PLAT protein |
CTD |
PMID:11107162 |
|
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
multiple interactions increases degradation |
ISO |
BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased degradation of PLCG1 protein] |
CTD |
PMID:16215670 |
|
NCBI chr 2:160,573,230...160,617,680
Ensembl chr 2:160,573,220...160,617,680
|
|
G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of RAF1 protein |
CTD |
PMID:10700234 |
|
NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
affects activity |
ISO |
N-acetylsphingosine affects the activity of RELA protein |
CTD |
PMID:12853972 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Rhob |
ras homolog family member B |
increases expression |
EXP |
N-acetylsphingosine results in increased expression of RHOB mRNA |
CTD |
PMID:18270325 |
|
NCBI chr12:8,547,661...8,550,009
Ensembl chr12:8,547,661...8,550,009
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
multiple interactions |
ISO |
[N-acetylsphingosine results in increased abundance of Ceramides] which results in decreased secretion of SERPINE1 protein |
CTD |
PMID:11107162 |
|
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
multiple interactions |
ISO |
N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased activity of SOD1 protein] |
CTD |
PMID:33959992 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
increases expression multiple interactions |
ISO |
N-acetylsphingosine results in increased expression of SOD2 mRNA; N-acetylsphingosine results in increased expression of SOD2 protein Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of SOD2 protein] |
CTD |
PMID:9535218 PMID:10428046 |
|
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Sts |
steroid sulfatase |
multiple interactions |
ISO |
N-acetylsphingosine inhibits the reaction [Tretinoin results in increased activity of STS protein] |
CTD |
PMID:16178010 |
|
NCBI chr X:168,856,332...169,015,037
Ensembl chr X:168,909,030...169,014,924
|
|
G |
Tfe3 |
transcription factor E3 |
multiple interactions |
ISO |
N-acetylsphingosine results in decreased phosphorylation of and affects the localization of TFE3 protein |
CTD |
PMID:29945972 |
|
NCBI chr X:7,628,769...7,641,441
Ensembl chr X:7,628,799...7,641,441
|
|
G |
Tgif1 |
TGFB-induced factor homeobox 1 |
increases expression |
EXP |
N-acetylsphingosine results in increased expression of TGIF1 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr17:71,151,200...71,160,527
Ensembl chr17:71,151,200...71,160,541
|
|
G |
Tjp1 |
tight junction protein 1 |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of TJP1 mRNA; N-acetylsphingosine results in decreased expression of TJP1 protein |
CTD |
PMID:28052715 |
|
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of TP53 protein] N-acetylsphingosine results in increased expression of TP53 mRNA; N-acetylsphingosine results in increased expression of TP53 protein |
CTD |
PMID:9535218 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Txn1 |
thioredoxin 1 |
decreases activity multiple interactions |
ISO |
N-acetylsphingosine results in decreased activity of TXN protein TXNIP affects the reaction [N-acetylsphingosine results in decreased activity of TXN protein] |
CTD |
PMID:18270325 |
|
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
|
|
G |
Txnip |
thioredoxin interacting protein |
increases expression multiple interactions |
ISO EXP |
N-acetylsphingosine results in increased expression of TXNIP protein N-acetylsphingosine results in increased expression of TXNIP mRNA; N-acetylsphingosine results in increased expression of TXNIP protein TXNIP affects the reaction [N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein]; TXNIP affects the reaction [N-acetylsphingosine results in decreased activity of TXN protein]; TXNIP affects the reaction [N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein] |
CTD |
PMID:18270325 |
|
NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
N-acetylsphingosine results in decreased expression of and results in decreased secretion of VEGFA protein |
CTD |
PMID:15313899 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
|
G |
Asah2 |
N-acylsphingosine amidohydrolase 2 |
multiple interactions |
ISO |
ASAH2 protein inhibits the reaction [TNF protein results in increased abundance of N-palmitoylsphingosine] |
CTD |
PMID:15946935 |
|
NCBI chr19:31,962,046...32,080,540
Ensembl chr19:31,959,997...32,085,611
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions increases expression |
EXP |
ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ATF4 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression multiple interactions |
EXP |
N-palmitoylsphingosine results in increased expression of ATF6 mRNA [N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ATF6 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
|
|
G |
Cs |
citrate synthase |
multiple interactions decreases expression |
EXP |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in decreased activity of CS protein; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in decreased activity of CS protein]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in decreased expression of CS mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
EXP |
N-palmitoylsphingosine results in increased expression of DDIT3 mRNA [N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of DDIT3 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of DDIT3 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of DDIT3 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Hspa5 |
heat shock protein 5 |
increases expression multiple interactions |
EXP |
N-palmitoylsphingosine results in increased expression of HSPA5 mRNA [N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of HSPA5 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of HSPA5 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of HSPA5 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Il1b |
interleukin 1 beta |
increases abundance multiple interactions |
ISO |
IL1B protein results in increased abundance of N-palmitoylsphingosine (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [IL1B protein results in increased abundance of N-palmitoylsphingosine] |
CTD |
PMID:27556861 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
multiple interactions increases expression |
EXP |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ITPR1 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ITPR1 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ITPR1 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
|
|
G |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
increases expression multiple interactions |
EXP |
N-palmitoylsphingosine results in increased expression of ITPR2 mRNA [N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ITPR2 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ITPR2 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ITPR2 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr 6:146,009,797...146,403,757
Ensembl chr 6:146,009,797...146,403,721
|
|
G |
Lipc |
lipase, hepatic |
multiple interactions |
EXP |
[LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of N-palmitoylsphingosine |
CTD |
PMID:24777581 |
|
NCBI chr 9:70,705,410...70,859,503
Ensembl chr 9:70,705,410...70,859,508
|
|
G |
Lipg |
lipase, endothelial |
multiple interactions |
EXP |
[LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of N-palmitoylsphingosine |
CTD |
PMID:24777581 |
|
NCBI chr18:75,072,393...75,095,380
Ensembl chr18:75,072,393...75,094,334
|
|
G |
Mfn2 |
mitofusin 2 |
increases expression multiple interactions |
EXP |
N-palmitoylsphingosine results in increased expression of MFN2 mRNA [N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of MFN2 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of MFN2 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
|
|
G |
Pacs2 |
phosphofurin acidic cluster sorting protein 2 |
increases expression multiple interactions |
EXP |
N-palmitoylsphingosine results in increased expression of PACS2 mRNA [N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of PACS2 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of PACS2 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr12:112,977,998...113,038,021
Ensembl chr12:112,978,128...113,038,021
|
|
G |
Pcx |
pyruvate carboxylase |
multiple interactions |
EXP |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased activity of PC protein; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased activity of PC protein] |
CTD |
PMID:28223344 |
|
NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
|
|
G |
Tnf |
tumor necrosis factor |
increases abundance multiple interactions |
EXP ISO |
TNF protein results in increased abundance of N-palmitoylsphingosine Imipramine inhibits the reaction [TNF protein results in increased abundance of N-palmitoylsphingosine] ASAH2 protein inhibits the reaction [TNF protein results in increased abundance of N-palmitoylsphingosine] |
CTD |
PMID:15946935 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
multiple interactions |
EXP |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of VDAC1 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of VDAC1 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224
|
|